CLINICAL_TRIALS
trial_result
· 2012-11-30
Clinical Trial Update: LBH589 Treatment for Refractory Clear Cell Renal Carcinoma [Phase 2]
Summary
Phase 2 trial update for LBH589 in refractory clear cell renal carcinoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SCRI Development Innovations, LLC | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2012-11-30